| 000 | 01652 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514003423.0 | ||
| 264 | 0 | _c20010726 | |
| 008 | 200107s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(20010701)92:1<165::aid-cncr1305>3.0.co;2-f _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBirner, P | |
| 245 | 0 | 0 |
_aExpression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis. _h[electronic resource] |
| 260 |
_bCancer _cJul 2001 |
||
| 300 |
_a165-71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xbiosynthesis |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdiagnosis |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xbiosynthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHypoxia-Inducible Factor 1 |
| 650 | 0 | 4 | _aHypoxia-Inducible Factor 1, alpha Subunit |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xphysiopathology |
| 650 | 0 | 4 |
_aNuclear Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aOligodendroglioma _xdiagnosis |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTranscription Factors |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 700 | 1 | _aGatterbauer, B | |
| 700 | 1 | _aOberhuber, G | |
| 700 | 1 | _aSchindl, M | |
| 700 | 1 | _aRössler, K | |
| 700 | 1 | _aProdinger, A | |
| 700 | 1 | _aBudka, H | |
| 700 | 1 | _aHainfellner, J A | |
| 773 | 0 |
_tCancer _gvol. 92 _gno. 1 _gp. 165-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(20010701)92:1<165::aid-cncr1305>3.0.co;2-f _zAvailable from publisher's website |
| 999 |
_c11372432 _d11372432 |
||